Investor Relations

The Ambu share has a track record of high performance. And growth is a strong parameter for our success

Latest news

19

Oct. 2017

Cross-contamination of bronchoscopes is a real problem

The evidence is clear, contamination is a big health issue, not only in endoscopy, but equally within bronchoscopy.

We have produced the short video below to illustrate the issue and raise awareness among health care professionals and patients alike.

For those with a special interest, we have compiled a booklet presenting key facts, explaining the complex reprocessing process and why these scopes cannot be guaranteed clean. Also includes a presentation of recent literature.

You can download the booklet: Is contamination of bronchoscopes really a problem? (pdf)

04

Oct. 2017

Ambu launches ambitious strategy towards 2020 (no. 1)

After exceeding the goals of the 2017 strategy, Ambu sets new goals and aims to double revenue in just three years. The key elements are a stable core business and disruptive single-use endoscopy technology.

In 2013, Ambu set ambitious goals. Under the heading “Climbing New Heights 2017”, Ambu set out to reach a DKK 2 billion revenue, increase earnings significantly and create strong free cash flows. The topline goal was reached a year ahead of time and with the guidance for 2016/17, the completion continues to look positive. Ambu will introduce the next chapter in its business strategy at a capital market day today in London.

We have been on a four-year journey that has transformed Ambu,” says CEO Lars Marcher. “Today, 25% of our revenue come from products that we did not have before 2013. That, to me, is testament to the power of innovation. We have proven that our new solutions are relevant to hospitals around the globe. Now, we look towards 2020. It took 75 years to reach 1 billion. Four years to reach 2 billion. Now, we will try to reach 5 billion in three years. It’s a stretch, but we aim for the Big Five.

Ambu’s new strategy is called “Big Five 2020” and targets stable core business growing more than the underlying market and an accelleration of growth through rapid expansion in the markets for Ambu’s single-use visualisation solutions and acquisitions of companies that support Ambu’s strategic direction.

At the capital market day Ambu will provide a long term guidance towards 2020 as well as a short term outlook for the financial year 2017/18. In addition, Ambu repeats its guidance for 2016/17 as it was announced on August 23, 2017.

Long term guidance towards 2020
Towards 2020 Ambu plans to grow organically by 13-15% annually and expand the EBIT-margin by more than 5%-pts and thereby generate an EBIT margin in the level of 24-25% in 2020. 

As for the free cash flows, Ambu expects to grow relative to revenue by accumulated 3%-pts to 18% in 2020 excluding impact from non-recurring investments in buildings. 

Guidance for the financial year 2017/18 that began on October 1, 2017
For the financial year 2017/18, Ambu expects an organic growth rate in the level of 13%, an EBIT-margin in the interval 20-21% and a free cash flow generation in the interval DKK 275-300m equal to 11% of revenue. The free cash flow includes investments in buildings of DKK 75m that equals approx. 3% of revenue. 

Guidance for the financial year 2016/17 that ended on September 30, 2017
The outlook for the financial year 2016/17 remains unchanged compared to the latest guidance provided on August 23, 2017. This is an organic growth of approx. 14%, an EBIT-margin of approx. 19% and free cash flows of approx. DKK 300m equal to 13% of revenue. The free cash flow includes investments in buildings of DKK 40 that equals approx. 2% of revenue.

Download
You can download this company announcement as a pdf file.

You can download the presentation of the Big Five 2020 strategy.

29

Sep. 2017

Financial Diary 2017/2018 (no. 19)

Financial Diary 2017/18

31 October 2017

Deadline for the inclusion of specific items on the agenda of the annual general meeting 2016/17

9 November 2017

Annual Report 2016/17 (Earnings release)

13 December 2017

Ordinary Annual General Meeting

31 January 2018

Report for Q1 2017/18

7 May 2018

Report for Q2 2017/18

23 August 2018

Report for Q3 2017/18

30 September 2018

End of fiscal year 2017/18

Financial Diary 2018/19

30 October 2018

Deadline for the inclusion of specific items on the agenda of the annual general meeting 2017/18

13 November 2018

Annual Report 2017/18 (Earnings release)

12 December 2018

Ordinary Annual General Meeting

Download

You can download this company announcement as a pdf file.

 

Financial Reports

Get the latest annual & quarterly reports
Read more

Annual Key Figures

Get an overview of Ambu's key figures
Read more

Presentations

Get the latest investor presentations and webcasts
Read more

Strategy

Learn more about Ambu's present strategy
Read more

Upcoming events

31

Oct. 2017

Deadline for the inclusion of specific items on the agenda of the annual general meeting 2016/17

09

Nov. 2017

Annual Report 2016/17 (Earnings release)

15

Nov. 2017

Jefferies 2017 London Healthcare Conference

London, 15 November 2017

News from Ambu

Sign up and receive news and company announcements from Ambu

Sign up

 

keyboard_arrow_up